Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties
about
Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASCChronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generationInflammation and its role in age-related macular degenerationMolecular mechanisms regulating NLRP3 inflammasome activationReactive oxygen species and mitochondria: A nexus of cellular homeostasisA clear and present danger: inflammasomes DAMPing down disorders of pregnancyThe PYRIN domain in signal transductionActivation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domainCo-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013Uncoupling of Pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasomeCurcumin: a double hit on malignant mesotheliomaImmune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic CellsNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesCutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expressionThe inflammasome NLRs in immunity, inflammation, and associated diseasesThe PYRIN connection: novel players in innate immunity and inflammation.The inflammasomes: mechanisms of activation and function.TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infectionGlucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome.Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemiaInternalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and releaseNeonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathwaysPathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesionsGenetics of Crohn disease, an archetypal inflammatory barrier disease.Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.CATERPILLERs, pyrin and hereditary immunological disorders.TIR, CARD and PYRIN: three domains for an antimicrobial triad.Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47.Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in miceNLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways.Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs.Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages.
P2860
Q24316380-4025E0EE-E88D-4C70-8605-A718D62192F2Q24683293-6587BDDA-8885-4918-8A2C-B7CA33FF5910Q26768520-D8AECFEA-EE1D-4657-98DF-12B06094A361Q26778556-50C10DE4-CADC-4A2F-B198-7F49EF4881CBQ26782529-C55D3FBD-1360-4987-AB87-FD019B51BCF1Q27007734-80FC2F13-5A5A-4FEB-9DEE-B12FAB2EBA6DQ28383855-A751F2E6-2F03-4A9A-AE45-B8DCF69B0F79Q28387719-233F60A2-6F15-465F-A336-9DA9AFE69D7BQ28391594-8FCC8872-A107-43DE-9378-4DA7E68E5778Q28393834-02E7E1F1-B744-4563-B2C5-BDF5618174C9Q28397518-68C6AAC0-FFC8-42D7-8BB7-338DF0978D50Q28554212-239B7A71-447D-462C-AC31-3F70C39529A9Q29248417-78A358DC-E3C6-4ECC-9B7A-BA9C9D8BB042Q29615589-9AA7302F-DD3D-4975-B82A-5332D630F3C0Q29616025-7C422397-6514-4B8C-B4DF-0C3037EDC651Q30956847-0D83F806-B8D7-43F7-B7AE-3526181DAAE8Q33748704-14242EB5-3AA8-4F2B-9FA5-5871991A5AF1Q34147516-113263ED-7FA7-4B58-AC82-4F919B434DBEQ34218546-D7E135BF-0C5D-468B-A650-9AE5581F7831Q34245112-FCE0837E-5CBE-454A-BAF6-E8E5D915AD1EQ34248184-3C7D572D-0A5B-4335-A575-0585EB6E0C24Q34262569-5210E98B-4E5D-4DBD-9307-6D9379486E24Q34329251-A80F3948-6E19-4AAA-B0C2-36A242BEA2CCQ34354320-2659B694-BFA5-408F-BA99-FB75E1C94737Q34367330-8236057B-E696-4F8C-A850-768ACC9A8ABEQ34479967-A423B773-9F5D-42A1-909B-A62825252D84Q34560380-9B729396-0960-4536-8456-3A0DC902A3D9Q35486035-878C6EE0-3BDD-40B7-98CB-EA164940D421Q35604251-0A06FA2E-3E15-4EE8-8CAF-117B54601644Q35902074-6CCE590F-2D57-477F-BFE5-4CEF718E0BFBQ36110574-510FB747-08A3-44D1-A076-19E5A05FE8D1Q36154204-5057DEA9-6FD4-433A-A714-2E0F58EC261AQ36344806-00E04261-CB0C-4874-9AF0-A9C5877DAD92Q36405072-1DE05842-E5E5-4CAD-B2A6-FFC99932DF7FQ36417755-23E2671B-0822-4F13-9ACE-892DCC2F7C82Q36507239-64FE50C1-7CBB-42CE-A046-32863EDDC4E2Q36592306-6EE72113-DBD7-40BE-A97E-2C7E7C99C9F9Q36839608-118FE550-9D4C-4306-8236-B41AD90D4C15Q36931680-B002EC4C-D23D-4CF5-968D-9032840DD1BDQ37036005-13FCE9BB-E9B8-4AD4-B164-6F7459F190A6
P2860
Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@ast
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en-gb
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@nl
type
label
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@ast
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en-gb
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@nl
prefLabel
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@ast
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en-gb
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@nl
P2093
P921
P3181
P1476
Cutting edge: CIAS1/cryopyrin/ ...... kappa B suppressive properties
@en
P2093
Jenny P-Y Ting
Jonathan A Harton
Michael W Linhoff
William O'Connor
Xinsheng Zhu
P304
P3181
P356
10.4049/JIMMUNOL.171.12.6329
P407
P577
2003-12-15T00:00:00Z